| Name | Title | Contact Details |
|---|---|---|
Nicole Nash |
Director of Sales Marketing | Profile |
Leah Robinson |
Director of Financial Services | Profile |
Leslie Webb |
Divisional Director of Sales | Profile |
Jacob Holt |
Financial Planning and Analysis Senior Director | Profile |
Jamie Vendegnia |
Human Resources Director | Profile |
Nexion Health Inc is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Fairview Health Services is a nonprofit, integrated health system providing exceptional health care across the full spectrum of health care services. Fairview’s broad continuum includes academic and community hospitals, primary and specialty care clinics, senior and long-term care facilities, retail and specialty pharmacies, pharmacy benefit management services, rehabilitation centers, counseling and home health care services, an integrated provider network, and health insurer PreferredOne. In partnership with the University of Minnesota, Fairview’s 25,000 employees and 2,600 employed and aligned providers embrace innovation and new thinking to drive a healthier future through healing, discovery and education.
Berkshire Health Systems is the leading provider of comprehensive health care services in the Berkshires. A private, not-for-profit organization, BHS serves the region through a network of affiliates which include Berkshire Medical Center, the BMC Hillcrest Campus, North Adams Campus of BMC, Fairview Hospital, and the Berkshire Visiting Nurse Association. BMC was recently ranked amongst the top 5% of all hospitals in the nation for Clinical Excellence by HealthGrades.
Northwest Imaging is a Shreveport, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.